Bone marrow-derived CD133+ stem cells for treatment of ischemic heart disease

Bone marrow-derived CD133+ stem cells can be used for treatment of ischemic heart disease. This trial aims to compare the effect of intra-coronary versus intramyocardial administration of autologous bone marrow-derived CD133+ stem cells for patients with ischemic heart disease.